Description

Flixotid Nebuli (fluticasone) suspension 0.5 mg/2 ml. 2 ml. №10

Ingredients:

Each 2 ml of Flixotid Nebuli suspension contains 0.5 mg of fluticasone.

Dosage:

The recommended dosage of Flixotid Nebuli is as prescribed by a healthcare professional. It is usually administered via inhalation using a nebulizer.

Indications:

Flixotid Nebuli is indicated for the maintenance treatment of asthma as a prophylactic therapy in adults and children. It helps to reduce inflammation in the airways, making breathing easier.

Contraindications:

Do not use Flixotid Nebuli if you are allergic to fluticasone or any other ingredients in the product. It is not intended for the treatment of acute asthma attacks.

Directions:

Follow the instructions provided by your healthcare provider on how to use Flixotid Nebuli. It is important to rinse your mouth with water after each use to prevent thrush.

Scientific Evidence:

Fluticasone, the active ingredient in Flixotid Nebuli, is a potent corticosteroid that exerts anti-inflammatory effects in the airways. Studies have shown that fluticasone can significantly reduce asthma symptoms and improve lung function when used regularly as a maintenance therapy. Research published in the Journal of Allergy and Clinical Immunology has demonstrated the efficacy of fluticasone in reducing airway inflammation and preventing asthma exacerbations.

Additional Information:

In addition to its anti-inflammatory properties, fluticasone in Flixotid Nebuli has been shown to have minimal systemic effects when inhaled, making it a safe and effective option for long-term asthma management. It is important to use Flixotid Nebuli regularly as prescribed to achieve optimal therapeutic outcomes and to consult a healthcare professional for any concerns or questions regarding its use.

Pharmacological Effects: Fluticasone acts locally in the lungs to reduce inflammation, swelling, and mucus production in the airways, thereby improving breathing and reducing the frequency of asthma symptoms.

Clinical Trials: Clinical trials have demonstrated the efficacy of Flixotid Nebuli in improving lung function, reducing the need for rescue inhalers, and enhancing overall asthma control in both adult and pediatric patients. These trials have highlighted the safety and tolerability of fluticasone when used as a maintenance therapy for asthma.